Question

Recall the HBS Case on Marriott​ Corporation, the levered equity beta was given as 0.97 for...

Recall the HBS Case on Marriott​ Corporation, the levered equity beta was given as 0.97 for Marriott as a whole. This beta might not be appropriate to calculate​ Marriott’s cost of equity because its target debt ratio​ (60%) going forward is quite different from its actual historical debt ratio​ (40%). Given that Marriott is planning to increase its leverage​ ratio, what should be the appropriate beta to be used in CAPM to calculate​ Marriott’s cost of equity in​ future?

A.

1.97

B.

1.94

C.

1.43

D.

1.00

E.

1.46

Homework Answers

Answer #1

Please refer to the image below for the solution-

Do leave an upvote if you find this helpful. In case of any doubt please let me know in the comment section.

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
Mark IV Industries' current debt to equity ratio is 0.4; it has a (levered) equity beta...
Mark IV Industries' current debt to equity ratio is 0.4; it has a (levered) equity beta of 1.4, and a cost of equity 15.2%. Risk-free rate is 4%, the market risk premium is 8%, the cost of debt is 4%, and the corporate tax rate is 34%. The firm is in a matured business, ie. it is not growing anymore. It has long-term debt outstanding that is rolled over when it matures, so that the amount of debt outstanding does...
You are calculating an equity required rate of return for Kings Corporation (KC) using the CAPM....
You are calculating an equity required rate of return for Kings Corporation (KC) using the CAPM. Rather than relying on the published beta for KC or calculating one yourself, you are going to base you required rate of return on the betas of two comparable companies: ABL and NBL. The debt-TA ratio of KC is 0.75 and the corporate tax rate is 0.21. The appropriate risk-free rate of return is 2.75 percent and the appropriate equity risk premium is 5.5...
8. An all-equity firm is considering financing its next investment project with a combination of equity...
8. An all-equity firm is considering financing its next investment project with a combination of equity and debt. The asset beta for the firm as a whole is 1.2 (recall that this is the same as the equity beta for an all-equity firm, but not the same as the equity beta for a “levered” firm). Assume the average rate of return on the market is 6% and the risk-free rate is 1%. The cost of debt for the company is...
Luna Corporation has a beta of 1.5, £10 billion in equity, and £5 billion in debt...
Luna Corporation has a beta of 1.5, £10 billion in equity, and £5 billion in debt with an interest rate of 4%. Assume a risk-free rate of 0.5% and a market risk premium of 6%. Calculate the WACC without tax. Queen Corporation has a debt-to-equity ratio of 1.8. If it had no debt, its cost of equity would be 16%. Its current cost of debt is 10%. What is the cost of equity for the firm if the corporate tax...
Simon Software Co. is trying to estimate its optimal capital structure. Right now, Simon has a...
Simon Software Co. is trying to estimate its optimal capital structure. Right now, Simon has a capital structure that consists of 20 percent debt and 80 percent equity, based on market values. (Its D/S ratio is 0.25.) The risk-free rate is 6 percent and the market risk premium, rM – rRF, is 5 percent. Currently the company’s cost of equity, which is based on the CAPM, is 12 percent and its tax rate is 40 percent. Find the new levered...
Question 1 The beta for the equity in Enough Corporation is 0.95. The market risk premium...
Question 1 The beta for the equity in Enough Corporation is 0.95. The market risk premium is 7 per cent, and the risk-free rate is 5 per cent. Enough has a target debt/equity ratio of 25 per cent. Its cost of debt is 9 per cent, before taxes. If the tax rate is 30 per cent, what is the WACC? Question 2 On 11 May 2010, Chase Manhattan had an issue of preference shares that traded for $80 per share....
Part B: Dividend Payout and Growth Ratios Recall from Module 1 the following two ratios: Internal...
Part B: Dividend Payout and Growth Ratios Recall from Module 1 the following two ratios: Internal growth rate = (ROA ? RR) / [1-(ROA ? RR)] (Eq. 3-30) where RR = Retention ratio = (Addition to retained earnings)/Net income (Eq. 3-31) – The internal growth rate measures the amount of growth a firm can sustain if it uses only internal financing (retained earnings) to increase assets Sustainable growth rate = (ROE ? RR) / [1-(ROE ? RR)] (Eq. 3-33) –...
Books Inc. is a publicly traded publishing company. It has a current stock price of $75...
Books Inc. is a publicly traded publishing company. It has a current stock price of $75 per share and an equity beta of 0.8. Books is consistently profitable and faces a marginal tax rate of 21%. It also maintains a target leverage ratio of 40%. Books’ debt is AAA-rated and can be considered essentially risk free. The risk free rate in the economy is 5% and the market premium is 4%. You may assume that the CAPM holds. Please use...
Eco Plastics Company Since its inception, Eco Plastics Company has been revolutionizing plastic and trying to...
Eco Plastics Company Since its inception, Eco Plastics Company has been revolutionizing plastic and trying to do its part to save the environment. Eco’s founder, Marion Cosby, developed a biodegradable plastic that her company is marketing to manufacturing companies throughout the southeastern United States. After operating as a private company for 6 years, Eco went public in 2012 and is listed on the Nasdaq stock exchange. As the chief financial officer of a young company with lots of investment opportunities,...
Illinois Bio Technologies Illinois Bio Technologies (IBTECH) was founded in Rosemont, Illinois, in 1992 by Kelly...
Illinois Bio Technologies Illinois Bio Technologies (IBTECH) was founded in Rosemont, Illinois, in 1992 by Kelly O'Brien, David Roberts, and Barbara Smalley. O'Brien and Roberts, both MDs, were on the research faculty at the Chicago Medical School at the time; O'Brien specialized in biochemistry and molecular biology, and Roberts specialized in immunology and medical microbiology. Smalley, who has a PhD, served a department chair of the Microbiology Department at the same school. The company started as a research and development...